Literature DB >> 6932517

Posttransfusion hepatitis in acute myelogenous leukemia. Effect on survival.

K A Foon, C Yale, K Clodfelter, R P Gale.   

Abstract

We evaluated retrospectively the clinical outcome of 47 patients with acute myelogenous leukemia who entered an intensive chemoimmunotherapy treatment protocol between January 1975 and July 1978. Remission duration and survival were substantially longer in patients in whom hepatitis developed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932517

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  1 in total

1.  No adverse prognostic influence of hepatitis B virus infection in acute childhood lymphoblastic leukemia.

Authors:  F Lampert; W R Willems; U Bertram; F Berthold
Journal:  Blut       Date:  1987-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.